Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic and Immunological Features of Bladder Cancer
I. R. Gilyazova, Kadriia Enikeeva, Guzel Rafikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9854-9854
Open Access | Times Cited: 17

Showing 17 citing articles:

Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications
Emanuela Germanà, Ludovica Pepe, Cristina Pizzimenti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6750-6750
Open Access | Times Cited: 6
CDCA4 promotes bladder cancer progression by JAK/STAT signaling pathway
Peng Wan, Yuan Ren, Hao Deng, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 2
Open Access
Emerging drivers of female bladder cancer: a pathway to precision prevention and treatment
Jianbin Zhang, Haixia Jia, Hui Han
Frontiers in Oncology (2025) Vol. 15
Open Access
Mechanistic Study of Liquiritigenin Inhibiting Bladder Cancer Cell Proliferation and Migration by Regulating STING1
Wuheng Li, Qiang Yin, Yihang Qiu, et al.
Cancer Genetics (2025)
Closed Access
Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers
Claire Shen, Richard Geng, S. Zhu, et al.
American journal of clinical and experimental immunology. (2024) Vol. 13, Iss. 4, pp. 187-194
Closed Access | Times Cited: 3
Association of interleukin6 rs1800796 gene polymorphism and serum level with bladder cancer in Egyptian population
Riyad T Mukhlif, Hassan Abol‐Enein, Afaf Elsaid, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysis
Jianzhong Zhang, Junyan Chen, M. Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis
Xiaojie Zhao, Xin Yu, Wen Ge Li, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 12, pp. 2414-2429
Open Access | Times Cited: 1
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids
Zikai Guo, Zhichao Li, Jia Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189199-189199
Open Access | Times Cited: 1
Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non–muscle-invasive bladder cancer using multi-layered –omics studies
Murat Akand, Tatjana Jatsenko, Tim Muilwijk, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Advances in the Role and Regulatory Mechanisms of ELK1 in Malignant Tumors
姣 何
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3391-3397
Closed Access
The prognostic significance and immune characteristics of bone morphogenetic proteins (BMPs) family: A pan-cancer multi-omics analysis
Changsheng Chen, Yu Zhang, Yuda Lin, et al.
Technology and Health Care (2024) Vol. 32, Iss. 6, pp. 4123-4175
Closed Access
Prognostic Value of TGF-β Expression in Bladder Cancer: A Systematic Review and Meta-analysis
Shima Kianmehr, Mohammad Vahabirad, Atefeh Seghatoleslam, et al.
Urology Research and Practice (2024) Vol. 50, Iss. 3, pp. 148-153
Open Access
Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer—From Early Detection to Prognosis
Natalia Jaszek, Alicja Bogdanowicz, Jan Siwiec, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7159-7159
Open Access
Biomarkers for predicting bladder cancer therapy response
Ioana Maria Mihai, Gang Wang
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 33, Iss. 3, pp. 533-547
Closed Access
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
Zhigang Huang, Bin Liu, Xiaoju Li, et al.
Neoplasia (2024) Vol. 60, pp. 101120-101120
Closed Access
Construction of a disulfidptosis-associated lncRNA signature to predict prognosis in bladder cancer
Jingsong Wang, Qingyuan Zheng, Jun Jian, et al.
Translational Andrology and Urology (2024) Vol. 13, Iss. 12, pp. 2705-2723
Open Access
The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway
Dongzhen Jiang, Huawei Zhang, Bingde Yin, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 13, pp. 1984-1998
Closed Access | Times Cited: 1
Page 1

Scroll to top